Literature DB >> 15827744

C1q nephropathy: features at presentation and outcome.

Keith K Lau1, Lillian W Gaber, Noel M Delos Santos, Robert J Wyatt.   

Abstract

The study population comprised all 20 patients followed since 1990 through December 2004 at the Le Bonheur Children's Medical Center with diagnosis of C1q nephropathy (55% boys; 60% African Americans). All were aged under 18 years at biopsy (mean 11.2 years, 65% aged 11 or over); the youngest presented at age 10 months and progressed to end-stage renal disease at 14 months. None had clinical or laboratory features of systemic lupus erythematosis or membranoproliferative glomerulonephritis. Clinical features assessed at diagnosis were age, gender, blood pressure, history of macroscopic hematuria, urinary protein to creatinine ratio, serum creatinine, estimated glomerular filtration rate, renal histology, and pattern for immunofluorescent reactants. At the time of biopsy 40% had nephrotic syndrome and 30% nephrotic range proteinuria without nephrotic syndrome. Three patients with nephrotic syndrome also had chronic renal insufficiency at diagnosis. The most common histological feature was focal segmental glomerulosclerosis in 40%, but 30% had minimal change lesion. Four patients, all with nephrotic syndrome at diagnosis, progressed to end-stage renal disease. Of the 12 patients not presenting with nephrotic syndrome, none had chronic renal insufficiency at last follow-up. Kidney survival was 94% and 78% at 1 and 5 years, respectively, in all patients and 88% and 49% in those presenting with nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827744     DOI: 10.1007/s00467-004-1810-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  C1q nephropathy: a case with severe atopic dermatitis.

Authors:  Mesiha Ekim; Aydan Ikinciogullari; Merih Berberoglu; Ozden Tulunay; Huriye Sencer; Nuray Ozkaya; Ismail Reisli; Necmiye Tumer
Journal:  Pediatr Nephrol       Date:  2002-06-11       Impact factor: 3.714

2.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

3.  Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

4.  Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy.

Authors:  J Mestecky; M Tomana; P A Crowley-Nowick; Z Moldoveanu; B A Julian; S Jackson
Journal:  Contrib Nephrol       Date:  1993       Impact factor: 1.580

Review 5.  The complement system in IgA nephropathy and Henoch-Schönlein purpura: functional and genetic aspects.

Authors:  R J Wyatt
Journal:  Contrib Nephrol       Date:  1993       Impact factor: 1.580

6.  Distinguishing C1q nephropathy from lupus nephritis.

Authors:  Andrew Sharman; Peter Furness; John Feehally
Journal:  Nephrol Dial Transplant       Date:  2004-03-05       Impact factor: 5.992

7.  IgG-associated primary glomerulonephritis in children.

Authors:  N Yoshikawa; K Iijima; M Shimomura; H Nakamura; H Ito
Journal:  Clin Nephrol       Date:  1994-11       Impact factor: 0.975

8.  C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome.

Authors:  J C Jennette; C G Hipp
Journal:  Am J Kidney Dis       Date:  1985-08       Impact factor: 8.860

9.  Iga nephropathy: presentation, clinical course, and prognosis in children and adults.

Authors:  R J Wyatt; B A Julian; D B Bhathena; B L Mitchell; N H Holland; H H Malluche
Journal:  Am J Kidney Dis       Date:  1984-09       Impact factor: 8.860

View more
  23 in total

1.  Pediatric C1q nephropathy and incidental proteinuria.

Authors:  Keith K Lau; Noel M Delos Santos
Journal:  Pediatr Nephrol       Date:  2006-04-08       Impact factor: 3.714

2.  Change in C1q deposition in C1q nephropathy.

Authors:  Kazunari Kaneko; Masafumi Hasui; Ken Hatae; Hidenori So; Ritsuko Katafuchi
Journal:  Pediatr Nephrol       Date:  2009-03-14       Impact factor: 3.714

Review 3.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

4.  C1q nephropathy with asymptomatic urine abnormalities.

Authors:  Masashi Nishida; Hidekazu Kawakatsu; Yasuko Okumura; Kenji Hamaoka
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

5.  C1q nephropathy in children: clinical characteristics and outcome.

Authors:  Vindya N Gunasekara; Neil J Sebire; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2013-12-11       Impact factor: 3.714

6.  C1q nephropathy in two young sisters.

Authors:  Jameela A Kari; Sawsan M Jalalah
Journal:  Pediatr Nephrol       Date:  2007-10-21       Impact factor: 3.714

7.  Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution.

Authors:  Martin Bitzan; Jodie D Ouahed; Preetha Krishnamoorthy; Chantal Bernard
Journal:  Pediatr Nephrol       Date:  2008-03-20       Impact factor: 3.714

8.  C1q nephropathy and minimal change nephrotic syndrome.

Authors:  Craig S Wong; Christopher A Fink; Jane Baechle; Alexis A Harris; Amy O Staples; John R Brandt
Journal:  Pediatr Nephrol       Date:  2008-12-11       Impact factor: 3.714

9.  A single-center study of C1q nephropathy in children.

Authors:  Isabel Roberti; Noosha Baqi; Shefali Vyas; Dae Un Kim
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

Review 10.  Current status and issues of C1q nephropathy.

Authors:  Akiko Mii; Akira Shimizu; Yukinari Masuda; Emiko Fujita; Kaoru Aki; Masamichi Ishizaki; Shigeru Sato; Adam Griesemer; Yuh Fukuda
Journal:  Clin Exp Nephrol       Date:  2009-04-17       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.